FDA Inspection 1287228 — Novacyl (Thailand) Ltd.

Novacyl (Thailand) Ltd. — FEI 3000287096

The FDA completed an inspection of Novacyl (Thailand) Ltd. on April 28, 2023 in Mueang Samut Prakan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mueang Samut Prakan (Thailand)

Additional Details

Mutual Recognition Agreement (MRA)